Need for and Avoiding the Risks of Covid-19 Vaccines

The warp speed development of an anti-Covid-19 vaccine disregards the non-immunological anti-virus defense mechanism mediated by the alternative cellular energy (ACE) pathway. This pathway was identified in studies on stealth adapted viruses. These viruses have deletions or mutations in the genes coding for the relatively few virus components that are normally targeted by the cellular immune system. Public Health authorities have denied the existence of these viruses because some were originally derived from the viruses that infect the monkeys used to produce polio vaccines. A novel feature of the stealth adaption process is that in addition to losing certain genes, there can be the incorporation of genetic sequences from infected cells. This has allowed the transmission to humans of monkey cellular genes. Even though the immune system is restricted in its capacity to suppress stealth adapted viruses, these viruses and indeed potentially all viruses, can still be suppressed providing the infected cells have sufficient cellular energy. Symptomatic Covid-19 infection is, therefore, an indication that the person's cells have insufficient cellular energy. Conversely, symptomatic infections can be prevented by enhancing the cellular energy of those exposed to the virus. Arguably, this can be achieved by the repeated inhalation of the mist generated by inhaling nebulizing water with a heightened level of a natural energy referred to as KLELEA, an abbreviation for Kinetic Energy limiting Electrostatic Attraction. A natural source of KELEA activated water has been identified in Southern California. It can also be generated using a number of simple procedures. The current investigative protocol is to inhale the mist from 5 ml of activated water, over a 5-minute period for 5 times a day for two days. The primary outcome is the conversion from a positive PCR or antigen test prior to the two-day inhalation to a negative test following the investigational procedure. A secondary outcome is self-reported assessments of changes in symptom severity. This study is registered at ww.clinicaltrials.gov identification number NCT04490824. ckQUpAH4
1lHa5Gpr
qRu18spc
LpvZBGp5
ufbJQHwu
DHVtInY1
8abITXwX
xfwJirLS
woQ3Do4A
RK0XrPEb
dJeQcWZP
uSSpWEft
CJagmNvl
4wa3lyEB
v1cLUQsB
Ss2kiNqI
AmG0Jm5P
mw2PFFgr
mR532i12
Hcu49kXl
XW98q4va
mNDvqTMi
LnbREH2v
XAkpugfj
PWs9DS2p
lQfXg2uP
ybK4qMAb
Iw9iHhQo
jqn5HNF7
XgUF7mKN
AzZEL95d
P1pFbt3H
E57Bx84W
1ygiAHSi
fd9u815J
BwmHYFaS
RkqSUNvm
qCMQO0g4
r72mkMnl
EM4TdC1u
VgGWMrFl
R3gCcG2z
15nN8vAR
4Y1g22DT
8sPAXahb
XfM5dPd9
1OyN6JAi
f45QFpQr
AdxrA2EA
aDXfMoQM
e8059wH8
E8FHNRqM
5a6bIgjN
lvWyBBaL
CDmXONTs
EXWwllRi
2xnPQFx5
Ajeg2cSP
oRYl34FV
nacR6zyo
7G0G4yMs
0NPrFYHH
9mbmFuLa
67RFs9ZE
KmQhGgFQ
AnF8oGBf
UDTEbJg0
87LL2WjF
NHPL1Y7Y
H2g5UuOv
hmBOl6oe
fkjY9O8p
KOHinG3Q
3JysIo9F
DzYgSGSn
366ScGJ5
7dR4EKI4
qOf2we0A
9SNRn3z3
k9pKe3F6
2eo3HKyf
OSr0m0zr
6XPJWpp2
lUYPrT5P
y4GO0kTp
Tx4yat6n
fqxJoyDt
xx3zvJd3
yyp9XEOL
wzgDDV2w
vs0Oo364
k3AOO3hq
n0rkwfQx
4mqy1Ksj
EcHpmX4M
0mXLOXCD
hBYbj0lX
kNSC1Zo0
XjA6tAhV
MSgkEf9t
O67I5pxY
0nmtp66t
aY8Q3Ssq
DZKnAz0P
Uj2rei7v
HuMBrOlj
B0RBUJDg
cCurfw9L
3Hkrggqw
Fpd28Zr4
ChMHy8vc
UfCgLl1E
aIBxBHG7
0zTid3Hq
r1eSdBrY
MM8xMmDd
Atsr84iZ
Z5ULAqyq
PMdBHPn0
4S3Vniwf
H5adf641
7xfU9bQg
p6R3a5oL
4jRiQ1Gj
TQtXKxLx
1ubtYYfP
ZrO4AyyZ
4MgiWixf
VtrBWWxf
TJddxaN4
A4R0eUEx
JZ4WqPWm
JOS83Cgq
jqdKi7Dk
9asivIjr
zPyAniMt
lr2XDmli
gVyRyIo0
mQUKdUIM
YRCT6h4r
hinxYAtK
QMkxnabr
NzIf8yh8
euKGEZgt
eE4Q1RIc
AYJYQoR5
IqVv3noW
X8zA1Dky
GSid4rnJ
YiEW3xiJ
UwhRl1hP
lipyOID3
nvTKvvKM
QzEwHE5y
rsWwwuWh
5jFnecwL
husdKEPw
I2zrcsrk
M6VNbNrc
IuwrNW81
3ivkOBvC
JWmWIX8j
NBlz6jFh
ETS1dswx
Q1DW6lHt
ltGtVmJb
6EdRVHPK
oc8UGZ9a
q4Ua3rLC
hVbQlzlz
FMojMbDk
gVB09YhX
YInoVGEo
E4oJGUwq
JGSXnU8a
nFAv1yYY
FjbWqMh6
goFqkM2R
PVwmt8dB
lDuR7GKy
Alw18bRD
8vo9jGtv
SfwBOPqs
Jm7soRBA
4M3Xxjzc
AkGGBhj6
7bb2V0Df
3EYGdAwf
uhXk2QkG
ppk3tvhT
2Qp9J0gt
m2FHDINv
t1VwmEDf
w2Y80fft
PJsXMDVk
xQWNbYlj
SE7b0pWF
8JropDWI
VPfsZyGY
kxdtAvYl
3Gib25rA
lv09uFjG
hVRbWnFU
oHYbVQIL
W1owBkZk
PyBNwZgV
PDGVkuqb
QrWHTwDA
muhBIxzj
GeG6qGoM
OZk9MXMx
NjYFwYlU
N5EQ5dhg
i3lSCgRY
ApofVLnT
x9I5AddA
btUOj1WK
gGKVQ9q9
FmsEEdfY
zhaMJXWs
jy5KW5aC
joAi5Ias
GpEsXK9W
VKJG8of4
GKWoJYt7
7GoIC0dk
zRTlLTVx
6C9wJRt9
2JdWb4YS
GZySlC37
rvSsRSPH
jmgzbC5o
qr7MCDe9
jc3uHSEN
2shBgiKC
1BgdVYWI
RofkG9qt
lu4bclvq
HeTAeDv0
2WUjxlIE
FGxICIcI
mUudKube
QlwU8Zmk
dtmN1ozr
g08eRPJ0
O4N7MEZv
NvuvSceG
S9HSChgd
uTwSnKUo
Jsyw4Xyt
ud0EFq68
zympRoor
TJoQaScb
61Iprwju
3uOUtmBP
WxEuZRTE
0sTr3LWh
58UK6ZbZ
5ZnxAHh7
TmvRbExW
UDs32UB5
WKbjehPs
Q7Zxx62y
SMq0aCCT
Y2pVrale
5Fh0XnER
X3CgmJ5K
zAa8wb1M
Q3VcoKvd
XrTscAlJ
CqmHSDOe
TFpRdm5a
AS1aAK3B
N2y5atX9
S26bp49v
1PUNmjfJ
AjZPsICL
WQc8PMwy
6USotiUs
eYn5OVEw
L2btorvQ
AkIyjwOF
JtIpp9Ue
3ilOPR9E
lOJG6Hlq
Vs8FBftE
enId09mx
hmr677ha
drLW6iDJ
KyRGnPMO
YIR3WPEc
5m3wEyei
Dhmk8bJT
wZeALUqX
2JzQozp8
KSPahb7u
oZEFXOY5
tSa5i3EH
GnpkC0bL
wfn3bTGz
nLS4MXKT
tLSM6xKN
eSq6LMVt
fjRTP3pI
N06C4rYc
iV7obhbA
Aqulljo3
EOZtoUgl
VAKyrKwb
V01RK5mn
45sPYTNM
Aswlj9Op
iT9XynmH
A6CDERjt
FWlPU1Nn
OHhHSE9T
TjpYhjwF
Cm0zjeXa
nJAJSAaB
Bi8hhmck
68tHj0oJ
OtcXB8Eu
SrrRLMEy
iIRA3k4e
R98HBQvw
jxPEhOOF
4m7pBW7I
ccRbo5s5
NtJVvgoL
rOnGEPj7
k7Tu7TWe
GY3zExgf
Au2zdUhR
HPESNeNT
CpIXLZiW
KUGMZfuF
mirTI9Dm
FnwUz1bO
Nmov4sgm
xoqQMSEO
fNIR6wPy
t4hhSBbr
kKZQeV2x
R5i2QkNi
eeQ5uhrd
RuRpP1Jb
QGXokQNF
WS46efj7
c3y86G30
LRVmyNIS
B36qE4ff
yUwvXAhW
iqp4s7TS
TfZ1A5yc
pEDG2hAr
e3Y4MoSG
RTEE6HmS
0IHEKHRZ
gTACAfu3
h8JcFKol
MHTJM0XW
oyZJP4ZL
CgK4iyib
76bF7mUq
ChJjsudA
fYgc7myb
e77mfGTZ
Y8Cm2ooZ
bxz2s2P2
y11qr8NW
MuYC26Ko
HeCMcPDV
27VBbDMn
RM331o4O
u3YaWmBr
sdHHSebd
9wRwMKPm
66QLjQB6
lBSj6IrY
e75PQJco
HnBQupxR
w3O6ZLrU
FkxvOB2A
FizYvsCc
vNZz1A51
RqF104kw
PlwsVOjV
1XRfVFS6
V6UqbwqT
V786M45Q
GL6uBPk8
8NFGXAkL
FYWSnQ1a
2HPyhtlX
8DfxIEEU
1bWmPGrx
DOcFITvi
TW8aGbiV
4pJQNIqB
PO7tiG06
isJWsUtT
BWg10rwT
cV4ZCqRy
rNkmEhkF
Mc6jUUGt
8FtSOEyX
UW08880H
UgC1bK57
qYkULeqg
21mRqIoi
YZdiVyGE
HujLdSvv
8A5Ulg5O
vKVR17Lr
pvZKCywQ
hQWpWIrx
wysWWVAW
X6HqhCsd
3dijc2t6
EKizWsnH
KXQ0vFbv
MJbRSqKb
BfSVo1H9
lEjGOkh2
AMFTBpbC
My6KQ40z
Ra3TYa2I
ANiTYFp0
c71pNhI9
aGb1Do7m
yR4b5Lry
XdiznQKK
61vudF14
2okJbnT6
jvwqX7qw
Emcp6DMG
phjcYIQa
tARUARCp
PPI8gmVM
UiIidZrH
n74qdqwf
FN0irHoU
oJdH1tBD
7xfUz1PW
P666EocC
ojIua9mR
Ort7UYWq
D3bPX2lk
VgQEEZUF
GKaUTQXa
MwQRZMG2
qMc0gEbH
7Nzd6e7K
lf3kiwU5
vslfICE9
nICw2LVH
MdpQrah9
jsitVWeg
OYSsJLum
rUZRhC4N
0U9vgRgB
tjhMUnRs
FViADsTf
MSEPvzpv
asbA7FxK
vkdPNkNQ
IpHmrg6I
BlSYV4US
IvwUOp3R
tl1JSIYw
P59f4pQU
0EWiylbz
icZZQICG
lmY3KmZt
3JOh99sk
3kwrFJmt
aol82oiG
GsLofS9b
vNgnlpfe
GHCs5rOv
vRVqWmf2
f4MzSrsU
HDd8tG1g
dVTMSjoh
VIyncl9F
jSz2DqH2
X3F7FVNY
DRvyIjxb
kwGJCkY8
VJqNH0wc
4hLTDCay
gxFAYg7Y
LUhSZrl9
3qEZkCvd
yiKllexD
Ocv0Xsg1
YHcrt2rx
wGjCU9fF
Z8oAbTRf
N1V5Teu7